TCR T-cell Therapies: What if Magic Bullets Simply Aren't Good Enough?
On the heels of a recent post in which I discussed evolving dynamics and strategic implications underscoring different types of...
On the heels of a recent post in which I discussed evolving dynamics and strategic implications underscoring different types of...
A common question I get from my cancer cell therapy clients at Cello Health BioConsulting is why, despite the lion share of clinical data...
What do medical market research and health economic outcomes research have in common? How can we combine our work on burden of disease in...
Amidst success of in vivo adeno-associated virus (AAV) based gene therapies, the gene therapy community awaits key outcomes from next...
The recent Chinese biopharma boom has been driven by six main factors: 1) Abundance of capital (government subsidies/funding, private...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net